B2B ad examples

تراجع اندماج الموظفين قد يكلّف شركتك أكثر مما تتوقع. مع عرب ثيرابي، استثمر في صحة موظفيك النفسية من خلال برامج رعاية مصممة لتناسب احتياجات مؤسستك.

Distortion specs are only part of the TEM performance story. When you look beyond resolution and consider measurement consistency, lab throughput, and the analytical capabilities, where do you go next? What will be your critical needs to deliver results with confidence? Our new 3-part semiconductor TEM analysis series explores: 01 Distortion and magnification calibration for more consistent measurements 02 Repeatability, throughput, and cost per sample 03 Expandable capabilities for memory and advanced packaging—including STEM, EDS, EELS, and 4D-STEM You’ll also receive a distortion infographic, expert video, and configuration content along the way. #Semiconductors #FailureAnalysis #SemiconductorEngineering #MaterialsAnalysis #ElectronMicroscopy #ThermoFisherScientific

¿Quieres mejorar tus evaluaciones ergonómicas? Aprende junto a profesionales del IBV y ERGONOVA cómo aplicar tecnología e IA con Ergo/IBV y ergoIA en salud laboral. 📅 17 de noviembre 🕒 11:30 AM – 12:30 PM (Argentina)

Wie wir bei Incyte Deutschland Impulse nutzen? Wir arbeiten zusammen daran etwas zu bewegen, geben einander den Freiraum Ideen voranzutreiben, und schoepfen Energie aus unseren Teams, die alle an einem Strang ziehen.

What does momentum look like at Incyte Germany? It’s the drive to build something meaningful, the freedom to move ideas forward and the energy of teams working together toward a shared ambition.

One day left - secure your spot now! How confident are you in your donor hemoglobin screening process? Join us for an expert-led webinar on how accurate Hb testing supports donor eligibility and blood quality. 📅 Date: Wednesday, 28 October, 2026 🕘 Time: 09:00 AM CET (Sweden) | 11:00 AM AST | 12:00 PM GST | 01:30 PM IST | 04:00 PM SGT/PHT | 06:00 PM AEST 🎤 Featuring HemoCue experts Annika Eriksson, Senior Specialist, Clinical & Scientific Affairs & Michael Aistrup Nielsen, Senior Global Product Manager, Hemoglobin 🔗 Register here: https://lnkd.in/dPRkqnEF

Darwin didn’t start with AI, and it won’t stand still. From machine learning models before the generative AI explosion to Darwin Context, Charlie, and Darwin PAth today, and Darwin Companion and Darwin Predict next, every solution builds on the last. Some will evolve into new versions; others will be superseded by future iterations of Darwin H/I. That’s Darwin’s ethos. Healthcare Revolution, Accelerated. Abarca Health • Darwin H/I • PBM Technology

Je weet best wat goed voor je is. Maar lukt het ook op een drukke werkdag? 🤔 Je wilt even wandelen tijdens de lunch, maar een meeting loopt uit. Je neemt je voor om wat vaker te bewegen, maar voor je het weet is de werkdag alweer voorbij. 𝗧𝗼𝗰𝗵 𝗹𝗶𝗴𝘁 𝗱𝗮𝘁 𝗻𝗶𝗲𝘁 𝗮𝗹𝗹𝗲𝗲𝗻 𝗮𝗮𝗻 𝗷𝗲𝘇𝗲𝗹𝗳. Ook je werkomgeving speelt een rol. Want hoe makkelijk is het om gezonde keuzes te maken als je agenda vol zit en er weinig ruimte is om even in beweging te komen? 😬 𝗚𝗲𝘇𝗼𝗻𝗱 𝗹𝗲𝘃𝗲𝗻 𝗼𝗽 𝗵𝗲𝘁 𝘄𝗲𝗿𝗸 𝗴𝗮𝗮𝘁 𝗱𝘂𝘀 𝗻𝗶𝗲𝘁 𝗮𝗹𝗹𝗲𝗲𝗻 𝗼𝘃𝗲𝗿 𝘄𝗮𝘁 𝗷𝗲 𝘇𝗲𝗹𝗳 𝗱𝗼𝗲𝘁, 𝗺𝗮𝗮𝗿 𝗼𝗼𝗸 𝗼𝘃𝗲𝗿 𝘄𝗮𝘁 𝗷𝗲 𝗼𝗺𝗴𝗲𝘃𝗶𝗻𝗴 𝗺𝗼𝗴𝗲𝗹𝗶𝗷𝗸 𝗺𝗮𝗮𝗸𝘁. In ons nieuwe artikel lees je waarom die omgeving zoveel verschil maakt en hoe organisaties gezonde gewoontes meer ruimte kunnen geven. Benieuwd? Lees het artikel hier: https://lnkd.in/e5DEPy-T Fijn weekend alvast! #Fitcoins #GezondLeven #Vitaliteit #GezondeWerkvloer #HR

One of the central challenges in precision oncology is identifying targets that are much more abundant on cancer cells than on healthy cells, and that therapies can physically reach and bind to. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) combines both characteristics: it is overexpressed in several solid tumors and is located on the cell surface, where it can be accessed by targeted therapies. CEACAM6 is a cell-surface glycoprotein expressed in some normal epithelial and myeloid cells.[1] In several solid tumors, however, its expression becomes dysregulated and can increase substantially, including in pancreatic, lung, colorectal, gastric, and breast cancers.[1–4] Importantly, its relevance extends beyond expression alone; elevated CEACAM6 has been associated with tumor progression, invasion, metastasis and poorer survival across multiple cancer types.[2,3,5,6] Its location on the outer cell surface also makes CEACAM6 accessible to targeted therapeutic approaches. Antibodies and antibody-based conjugates can be designed to recognize CEACAM6 on tumor cells, creating opportunities for more targeted treatment strategies.[1,4] The combination of cell-surface accessibility, differential expression and a role in aggressive tumor biology makes CEACAM6 a compelling target for the development of precision cancer therapies. #PrecisionOncology #TargetedTherapy #CancerBiology #Oncology #CancerResearch #TranslationalMedicine #LungCancer #BreastCancer #CEACAM6 #Tumor #Cancer

¿Parto en el agua o en posición vertical? Descubra las soluciones OB inalámbricas de Philips para ofrecer más movilidad y opciones durante el parto.

Mehr Wahlmöglichkeiten für Patientinnen – keine Einschränkung bei der Entbindung durch einengende Geräte und Kabel mit der kabellosen Avalon Lösung.

Nach einem gelungenen Auftakt geht die DOTS-Webinarreihe weiter: Sichern Sie sich Ihren Platz und treffen Sie die Myelom-Expert:innen online

Beliebtes Format mit erfolgreichem Auftakt: Sichern Sie sich jetzt Ihren Platz und erleben Sie praxisnahe Impulse zum Multiplen Myelom.

Hoe bespreekt u overgewicht en obesitas met uw patiënt? Verrijk uw kennis met de geaccrediteerde nascholing: https://lnkd.in/dNaE2Yyk

Hoe bespreekt u overgewicht en obesitas met uw patiënt? Verrijk uw kennis met de geaccrediteerde nascholing: https://lnkd.in/dNaE2Yyk

A New #Exclusive Partnership for Optohellas in Greece! We are honored to announce our exclusive partnership with HEINE Optotechnik a globally recognized name in high-quality medical diagnostic instruments. By joining forces with HEINE Optotechnik, we continue to expand our portfolio of premium medical equipment, supporting healthcare professionals with precision, quality & innovation. Optohellas is the #exclusive representative of HEINE Optotechniki n Greece. #Redefine_Vision_Together #Join_Optohellas_World_Partners_Network #Visit_us_at_EVRS_Booth_8 #Visit_us_at_Cyprus_Booth_9 #Visit_us_at_FLORetina_Booth_14 #Visit_us_at_ESCRS_Cairo

O cuidado que faz parte da nossa história acontece todos os dias. E vai muito além do que se vê. Na assistência ou nos bastidores, são pessoas que, com diferentes atuações, compartilham o mesmo compromisso: oferecer um cuidado único a cada paciente. No segundo episódio da websérie Cuidado Além do Tempo, uma celebração aos nossos 50 anos, profissionais compartilham histórias e experiências que revelam como pequenos gestos, grandes encontros e dedicação fazem a diferença na vida de tantas pessoas. Assista ao segundo episódio e descubra como o nosso jeito de cuidar ganha vida todos os dias!

Characterise more than 40 common respiratory viruses with targeted enrichment and a streamlined respiratory virus research workflow.

Characterise more than 200 RNA and DNA viruses and subtypes with targeted whole-genome sequencing for viral surveillance research.

🎗️ When facing a liver lesion, every step towards a diagnosis matters. For some patients, uncertainty around a liver lesion can mean an anxious wait before knowing what comes next. 💫 The HOPE initiative was created with one goal: to help speed up this journey by bringing different medical expertise together, from radiology and pathology to liver surgery, to establish a diagnosis and define the next steps in patient care. 🎥 In Episode 3️⃣ of our Liver Cancer Awareness series, Prof. Maxime Ronot, founder of the HOPE initiative, explains how this approach can make a difference for patients. 👇 Watch the video to learn more. 🔜 Stay tuned for the 4th and final episode of our series! #LiverCancerAwareness #LiverCancer #PatientCare #MultidisciplinaryCare #Healthcare #Radiology

Join us to explore the latest advances in testing for systemic amyloidosis, complement disorders, multiple sclerosis, and monoclonal gammopathies.

Join Dr. Amos Simon, Research Scientist and Laboratory Head, Sheba Medical Center, as he explores laboratory strategies for evaluating the complement system.

AI isn’t just changing how pharma works. It’s changing what teams expect from their partners. Speaking from #ESMO26, Robert J. Britting Jr., PhD, MBA reflects on the conversations he’s having with clients, from the need for a partner across the full commercialization journey to using AI to empower people and work more effectively. Hear Rob’s perspective on how AI is shaping commercialization across the oncology landscape. Come and continue the conversation with us at booth 1005. #ESMO26 #ReimagineHealth #IntelligentCommercialization #Oncology #AI

AI is no longer the answer to everything. It’s becoming table stakes. Speaking from ESMO 2026, Dean McAlister, EVP at Inizio, reflects on how the conversation is shifting from AI itself to how people use it to make a meaningful difference for patients. The opportunity is augmented intelligence: combining AI with human expertise to turn complex science into better outcomes for patients. That’s Intelligent Commercialization™ in action. Hear Dean’s perspective, and come and see us at booth 1005. #ESMO26 #ReimagineHealth #IntelligentCommercialization #Oncology #AI